● Recruiting

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Condition: Healthy Participants · Hemophilia A · Hemophilia B · Sponsor: Equilibra Bioscience LLC

PhasePhase 1

Planned participants31

Who can joinAll sexes, 18 Years to 60 Years

Healthy volunteersYes

About this study

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) of SR604 in healthy participants (Part A) and to evaluate the safety, tolerability, PK, PD, and efficacy of SR604 in participants with Hemophilia A or Hemophilia B, or Factor VII (FVII) deficiency, with or without inhibitors (Part B).

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Trials · 925-490-0278 · inf@equilibrabioscience.com

Always discuss trial participation with your own doctor first.

Locations (10)

California Clinical Trials Medical Group (CCTMG)	Glendale, California, United States	Completed
Children's Hospital Los Angeles	Los Angeles, California, United States	Recruiting
Rush University Medical Center	Chicago, Illinois, United States	Recruiting
LA Center for Bleeding and Clotting Disorders - Metairie	Metairie, Louisiana, United States	Recruiting
University of Michigan Hospitals - Michigan Medicine	Ann Arbor, Michigan, United States	Recruiting
Washington University School of Medicine	St Louis, Missouri, United States	Recruiting
Brody School of Medicine at East Carolina University	Greenville, North Carolina, United States	Not Yet Recruiting
Penn State Milton S Hershey Medical Center Pediatrics	Hershey, Pennsylvania, United States	Recruiting
Perelman Center for Advanced Medicine (PCAM)- Penn Blood Disorders Program	Philadelphia, Pennsylvania, United States	Recruiting
McMaster University Medical Centre, Hamilton Health Sciences	Hamilton, Ontario, Canada	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06349473